Mepolizumab Long-term Study to Assess Real World Safety and Effectiveness of Eosinophilic Granulomatosis With Polyangiitis (EGPA) in Japan
Clinical trial NCT04551989 · COMPLETED
Trial details
- NCT number
- NCT04551989
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2020-12-11
- Primary completion
- 2023-04-27
- Enrollment
- 118
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.